Compare OMH & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OMH | VVOS |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6M | 17.7M |
| IPO Year | 2023 | 2020 |
| Metric | OMH | VVOS |
|---|---|---|
| Price | $0.80 | $2.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | 41.9K | ★ 119.6K |
| Earning Date | 04-17-2026 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $10,264,748.00 | ★ $17,317,000.00 |
| Revenue This Year | $28.40 | $17.96 |
| Revenue Next Year | $23.07 | $55.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 78.86 | 18.76 |
| 52 Week Low | $0.59 | $1.93 |
| 52 Week High | $5.10 | $7.95 |
| Indicator | OMH | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 43.74 | 42.20 |
| Support Level | $0.80 | $1.94 |
| Resistance Level | $0.84 | $2.07 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 18.60 | 35.21 |
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.